Compounds > foscarnet

foscarnet and mycophenolic acid

foscarnet has been researched along with mycophenolic acid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
De Smet, S; Haouy, S; Poirée, M; Rocher, F; Saint-Paul, MC; Sirvent, A; Sirvent, N1
Bidier, M; Enk, A; Hadaschik, E; Hartmann, M; Pushkarevskaya, A1
Atsuta, Y; Eto, T; Fukuda, T; Hirakawa, A; Ichinohe, T; Ikegame, K; Inamoto, Y; Inoue, M; Kimura, T; Kuwatsuka, Y; Miyamura, K; Najima, Y; Okamoto, S; Ozawa, Y; Uchida, N1

Reviews

1 review(s) available for foscarnet and mycophenolic acid

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for foscarnet and mycophenolic acid

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
Isolated esophageal ulcerations in immunocompromised patients: mycophenolate mofetil or foscarnet, who is guilty?
    Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:8

    Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cytomegalovirus Infections; Esophageal Diseases; Female; Foscarnet; Humans; Immunocompromised Host; Mycophenolic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ulcer

2011
Viral reactivation imitates relapse of pemphigus vulgaris in an immunosuppressed patient.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017, Volume: 15, Issue:11

    Topics: Autoantibodies; Combined Modality Therapy; Cytomegalovirus; Debridement; Desmoglein 1; Desmoglein 3; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Humans; Immunosuppression Therapy; Middle Aged; Mycophenolic Acid; Pemphigus; Prednisolone; Recurrence; Virus Activation

2017
Use of unapproved or off-label drugs in Japan for the treatment of graft-versus-host disease and post-transplant viral infection.
    International journal of hematology, 2020, Volume: 112, Issue:6

    Topics: Acute Disease; Adult; Beclomethasone; Chronic Disease; Cidofovir; Cytomegalovirus Infections; Etanercept; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infliximab; Japan; Male; Middle Aged; Mycophenolic Acid; Off-Label Use; Postoperative Complications; Registries; Transplantation, Homologous; Virus Diseases

2020